Grants and Contributions:
Title:
Germany ZIM - BARACUDA - Bioprinted Platform of Next Generation Cancer Models with Human-Like Vascularization for Preclinical Drug Development
Agreement Number:
1018497
Agreement Value:
$497,000.00
Agreement Date:
May 1, 2024 - Mar 31, 2026
Description:
As part of the international consortium project “Bioprinted Platform of Next Generation Cancer Models with Human-Like Vascularization for Preclinical Drug Development”, this project will validate a 3D bioprinted tissue model platform as a viable tool for the development of personalized cell therapies and identify therapeutic T-Cell candidates for further development.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Victoria, British Columbia, CA V9A 0C6
Reference Number:
172-2024-2025-Q1-1018497
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
719330532
Recipient Type:
For-profit organization
Recipient's Operating Name:
VoxCell BioInnovation Inc.
Recipient's Legal Name:
Voxcell Bioinnovation Inc.
Federal Riding Name:
Victoria
Federal Riding Number:
59041
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
541710